DE69431194T2 - AMIDINO DERIVATIVES USEFUL AS NO SYNTHASE INHIBITORS - Google Patents

AMIDINO DERIVATIVES USEFUL AS NO SYNTHASE INHIBITORS

Info

Publication number
DE69431194T2
DE69431194T2 DE69431194T DE69431194T DE69431194T2 DE 69431194 T2 DE69431194 T2 DE 69431194T2 DE 69431194 T DE69431194 T DE 69431194T DE 69431194 T DE69431194 T DE 69431194T DE 69431194 T2 DE69431194 T2 DE 69431194T2
Authority
DE
Germany
Prior art keywords
pct
synthase inhibitors
derivatives useful
amidino derivatives
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69431194T
Other languages
German (de)
Other versions
DE69431194D1 (en
Inventor
S Tjoeng
F Fok
Keith Webber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of DE69431194D1 publication Critical patent/DE69431194D1/en
Publication of DE69431194T2 publication Critical patent/DE69431194T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Abstract

PCT No. PCT/US94/11724 Sec. 371 Date Mar. 20, 1996 Sec. 102(e) Date Mar. 20, 1996 PCT Filed Oct. 18, 1994 PCT Pub. No. WO95/11014 PCT Pub. Date Apr. 27, 1995The current invention discloses amidino derivatives useful as nitric oxide synthase inhibitors.
DE69431194T 1993-10-21 1994-10-18 AMIDINO DERIVATIVES USEFUL AS NO SYNTHASE INHIBITORS Expired - Fee Related DE69431194T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13997093A 1993-10-21 1993-10-21
PCT/US1994/011724 WO1995011014A1 (en) 1993-10-21 1994-10-18 Amidino derivatives useful as nitric oxide synthase inhibitors

Publications (2)

Publication Number Publication Date
DE69431194D1 DE69431194D1 (en) 2002-09-19
DE69431194T2 true DE69431194T2 (en) 2002-12-12

Family

ID=22489151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69431194T Expired - Fee Related DE69431194T2 (en) 1993-10-21 1994-10-18 AMIDINO DERIVATIVES USEFUL AS NO SYNTHASE INHIBITORS

Country Status (11)

Country Link
US (1) US5821267A (en)
EP (1) EP0724435B1 (en)
JP (1) JPH09504524A (en)
AT (1) ATE222100T1 (en)
AU (1) AU8078394A (en)
CA (1) CA2170735A1 (en)
DE (1) DE69431194T2 (en)
DK (1) DK0724435T3 (en)
ES (1) ES2181726T3 (en)
PT (1) PT724435E (en)
WO (1) WO1995011014A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821267A (en) * 1993-10-21 1998-10-13 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
WO1995024382A1 (en) * 1994-03-10 1995-09-14 G.D. Searle & Co. L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
AU682768B2 (en) * 1994-05-07 1997-10-16 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
US5684008A (en) 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
WO1996021445A1 (en) * 1995-01-13 1996-07-18 The General Hospital Corporation Methods of inhibiting neurodegenerative diseases
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
CA2272941A1 (en) * 1997-01-09 1998-07-16 Daniela Salvemini Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain
US6291514B1 (en) 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
EP1054886B1 (en) * 1998-02-09 2002-09-04 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
US6552052B2 (en) 1998-06-10 2003-04-22 Monsanto/G.D. Searle Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors
EA200100882A1 (en) * 1999-02-09 2002-04-25 3-Дименшенл Фамэсьютикэлс, Инк. AMETHINE, METHYLAMIDINE AND GUANIDA HEAT HYDROARIAL PRODUCTS (OPTIONS) MATERIALS (OPTIONS), PHARMACEUTICAL COMPOSITION (OPTIONS), METHOD FOR INHIBING PROTEASE (OPTIONS) AND SPODA SPEEDS (OPTIONS), SPEED INHIBITION (OPTIONS) AND SPODA PRODUCTS (OPTIONS);
JP2001220386A (en) * 1999-11-30 2001-08-14 Takeda Chem Ind Ltd Method for producing oxadiazoline derivative
AU2001247745B2 (en) 2000-03-24 2006-08-31 Pharmacia Corporation Amidino compounds useful as nitric oxide synthase inhibitors
AR030416A1 (en) 2000-04-13 2003-08-20 Pharmacia Corp HALOGENATED DERIVATIVE COMPOUND OF HEPTENOIC ACID 2-AMINO-3,4, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE IN THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT AS AN INHIBITOR OF SYNTHETIC NITRIC OXIDE
US6545170B2 (en) 2000-04-13 2003-04-08 Pharmacia Corporation 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
US6956131B2 (en) 2000-04-13 2005-10-18 Pharmacia Corporation 2-amino-3, 4 heptenoic compounds useful as nitric oxide synthase inhibitors
AR032318A1 (en) 2000-04-13 2003-11-05 Pharmacia Corp HALOGENATED DERIVATIVE COMPOUND OF HEPTENOIC ACID 2-AMINO-5,6; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE IN THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT AS AN INHIBITOR OF NITRICAL SYNTHEASE OXIDE
AR034120A1 (en) 2000-04-13 2004-02-04 Pharmacia Corp HALOGENATED DERIVATIVE COMPOUND OF HEPTENOIC ACID 2-AMINO-4,5, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND THE USE OF SUCH COMPOUND AND SUCH COMPOSITION IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO INHIBIT OR MODULATE NITRIC ACID SYNTHESIS
US6787668B2 (en) 2000-04-13 2004-09-07 Pharmacia Corporation 2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
US7012098B2 (en) 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
TW200744658A (en) * 2005-10-12 2007-12-16 Pentapharm Ag Topical composition for use as a skin lightener
US9688668B2 (en) 2012-02-08 2017-06-27 University Of Virginia Patent Foundation Long chain base sphingosine kinase inhibitors
IT202200000347A1 (en) * 2022-01-12 2023-07-12 Istituti Clinici Scient Maugeri Spa Sb Compounds useful in the prevention and/or treatment of pathologies and diseases associated with senescent cells.

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3445517A (en) * 1966-06-03 1969-05-20 Lilly Co Eli Aryl acetamidines
GB1188956A (en) * 1967-07-14 1970-04-22 Delalande Sa N-Substituted Aromatic Amidines and process for obtaining same
US3978202A (en) * 1975-07-25 1976-08-31 Stauffer Chemical Company ο-Chlorobenzamidoxime as an anti-inflammatory agent
US3978219A (en) * 1975-07-25 1976-08-31 Stauffer Chemical Company Nicotinamidoxime as an anti-inflammatory agent
JPS59139357A (en) * 1983-01-28 1984-08-10 Torii Yakuhin Kk Amidine derivative
DE3505555A1 (en) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg NEW OLIGOPEPTIDYLARGININOL DERIVATIVES AND THEIR HOMOLOGOLOGY, METHOD FOR THE PRODUCTION THEREOF, THE USE THEREOF AND MEANS CONTAINING THEM
US5196450A (en) * 1985-12-19 1993-03-23 Merrell Dow Pharmaceuticals Inc. Method of inhibiting protozoal growth
ZA898440B (en) * 1988-11-10 1990-07-25 Merrell Dow Pharma Lactamimides in the treatment of drug-resistant protozoal infections
US5059712A (en) * 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
WO1992004054A1 (en) * 1990-08-30 1992-03-19 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon Substituted amidines having high binding to the sigma receptor and the use thereof
JPH06507392A (en) * 1991-02-26 1994-08-25 エイアールシー　１，インコーポレイテッド Compositions and methods for the treatment of sympathetic persistent pain
US5132453A (en) * 1991-03-22 1992-07-21 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
US5273875A (en) * 1991-03-22 1993-12-28 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
DK0518819T3 (en) * 1991-06-11 1995-09-25 Ciba Geigy Ag Amidino compounds, their preparation and use as a drug
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
JPH06510760A (en) * 1991-08-27 1994-12-01 ジ・アップジョン・カンパニー Metabolic disorders and metabolic treatments
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
US5801144A (en) * 1992-01-28 1998-09-01 Karpas; Abraham Use of a compound for the manufacture of a medicament for the treatment of HIV infection
US5296466A (en) * 1992-02-19 1994-03-22 Board Of Regents, The University Of Texas System Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
US5340833A (en) * 1992-05-01 1994-08-23 Eisai Co., Ltd. Urokinase inhibitors
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
US5350770A (en) * 1992-07-28 1994-09-27 Elford Howard L Therapeutic process for the treatment of septic shock
US5455274A (en) * 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives
JPH06287180A (en) * 1993-03-31 1994-10-11 Yamanouchi Pharmaceut Co Ltd Amidinoidazole derivative
GB9301289D0 (en) * 1993-01-22 1993-03-17 Smithkline Beecham Plc Novel composition
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
US5424447A (en) * 1993-07-07 1995-06-13 The Medical College Of Wisconsin Research Foundation, Inc. Heme binding compounds and use thereof
US5821267A (en) * 1993-10-21 1998-10-13 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
US5364881A (en) * 1993-11-15 1994-11-15 The Medical College Of Wisconsin Research Foundation, Inc. S-alkyl-isothioureido-amino acids and use thereof
US5362744A (en) * 1993-11-22 1994-11-08 Warner-Lambert Company Tetrazole-substituted urea acat inhibitors
EP0776886A4 (en) * 1994-08-18 1999-05-12 Chugai Pharmaceutical Co Ltd Amino acid derivative having nitrogen monoxide synthetase inhibitor activity

Also Published As

Publication number Publication date
CA2170735A1 (en) 1995-04-27
JPH09504524A (en) 1997-05-06
DK0724435T3 (en) 2002-11-25
EP0724435B1 (en) 2002-08-14
AU8078394A (en) 1995-05-08
ES2181726T3 (en) 2003-03-01
PT724435E (en) 2002-11-29
US5821267A (en) 1998-10-13
WO1995011014A1 (en) 1995-04-27
DE69431194D1 (en) 2002-09-19
EP0724435A1 (en) 1996-08-07
ATE222100T1 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
DE69431194D1 (en) AMIDINO DERIVATIVES USEFUL AS NO SYNTHASE INHIBITORS
NZ305799A (en) Cyclic amidino agents useful as nitric oxide synthase inhibitors
NO942064L (en) inhibitors
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
ATE297898T1 (en) 4-CARBOXAMINO-2-SUBSITUTED-1,2,3,4-TETRAHYDROCINOLINES AS CETP INHIBITORS
NO975716L (en) imidazole
UA34466C2 (en) Agent for non-systemic control of parasites
TW353067B (en) Isoquinolines
MX9700557A (en) Dihydrobenzofuranes.
SI0889886T1 (en) Novel phenanthridines substituted in the 6 position
BR9608873A (en) Small molecule di and trivalent selectin inhibitors
DE69703201T2 (en) HYDROXYAMIDE DERIVATIVES CAN BE USED AS STICKOXIDE SYNTHESIS INHIBITORS
DK0579681T3 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and its use
ZA949151B (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents.
GB2324091A (en) Metalloproteinase inhibitors
ATE183100T1 (en) NOVEL GLUCOHYDROLASE INHIBITORS USEFUL AS ANTIDIABETIC, ANTIVIRAL AND ANTIMETASTATIC AGENTS
AU2002224322A1 (en) Lactam dipeptide and its use in inhibiting beta-amyloid peptiderelease
TW328951B (en) Substituted 2-phenylpyridines
MXPA04005226A (en) 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof.
IT1316050B1 (en) POLYNITRAMIN, ITS SYNTHESIS AND HYDROTECHNICAL COMPOSITIONS.
FR2682064B1 (en) PRINTER, ESPECIALLY PORTABLE OFFICE PRINTER.
MX9203166A (en) 1 - [(2-FLUOROFENIL) (4-FLUOROFENIL) FENILMETIL] -IH-IMIDAZOL.
MX9800053A (en) Benzylated cis-2,3-epoxycycloalkanol herbicides.
GB0113920D0 (en) Composition
PT971714E (en) METHOD USING CYCLOOXIGENASE-2 INHIBITORS IN TREATMENT AND PREVENTION OF DEMENTIA

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee